CNS Pharmaceuticals, Inc. Preferred Stock, Shares Authorized
CNS Pharmaceuticals, Inc. (CNSP) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-12
- 2026-06-30: Preferred Stock, Shares Authorized 5.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2025-11-20: Preferred Stock, Shares Authorized 5.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 5.00M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 5.00M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 5.00M shares 10-Q · filed 2026-08-12 |
| 2025-11-20 | 5.00M shares 10-Q · filed 2026-08-12 |
| 2025-11-19 | 416.67K shares 10-Q · filed 2026-08-12 |
| 2025-09-30 | 416.67K shares 10-Q · filed 2025-11-14 |
| 2025-07-22 | 416.67K shares 10-Q · filed 2026-08-12 |
| 2025-07-21 | 5.00M shares 10-Q · filed 2026-08-12 |
| 2025-06-30 | 416.67K shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 5.00M shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 5.00M shares 10-K · filed 2026-03-31 |
| 2024-09-30 | 5.00M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 5.00M shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 5.00M shares 10-Q · filed 2024-05-15 |
| 2023-12-31 | 5.00M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 5.00M shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 5.00M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 5.00M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 5.00M shares 10-K · filed 2024-04-01 |
| 2022-09-30 | 5.00M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 5.00M shares 10-Q · filed 2022-08-12 |
| 2022-03-31 | 5.00M shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 5.00M shares 10-K · filed 2023-03-31 |
| 2021-09-30 | 5.00M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 5.00M shares 10-Q · filed 2021-08-13 |
| 2021-03-31 | 5.00M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 5.00M shares 10-K · filed 2022-03-03 |
| 2020-09-30 | 5.00M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 5.00M shares 10-Q · filed 2020-08-10 |
| 2019-12-31 | 5.00M shares 10-K · filed 2021-02-12 |
| 2019-09-30 | 5.00M shares 10-Q · filed 2019-12-20 |
| 2018-12-31 | 5.00M shares 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |